Students of the year 2013
Felix Adams GERMANY
supervisor: Prof. Dr. Dr. Schambach / Dr. Adrian Schwarzer, Experimental Hematology, OE 6960,
project: Using inducible gene expression and RNAi to investigate murine models of acute T-cell leukemia in vivo
Final exam November 2017. MARVECS GmbH (Roche Pharma AG), Essen
Chidiebere Awah NIGERIA
supervisor: PD Dr. Stanke, Pediatric Pneumology, OE 6710,
project: Functional analysis of regulatory variants of modifying genes that determine the outcome of the monogenic disease cystic fibrosis
Final exam November 2016. Dr Adam Sonabend Laboratory, Columbia University Medical Center, New York
Nurullah Aydogdu TURKEY
supervisor: Prof. Dr. Kispert, Molecular Biology, OE 5250,
project: Wnt signaling in ureter development
Final exam November 2017. ATIGEN-CELL Technology company, Trabzon, Turkey; now Regenerative Medicine and Stem Cell Center, Liv Hospital, Istanbul
Ronja-Melinda Komoll GERMANY
supervisor: Prof. Ott/ Dr. Balakrishnan, Gastroenterology/ TwinCore, OE 6810,
project: MicroRNAs in hepatocelluar carcinoma
Ronja was class speaker!
Final exam November 2017. Quality Specialist, Epredia, Braunschweig
Michal Koska GERMANY
supervisor: Prof. Dr. Häussler, TWINCORE, OE 9654,
project: Molecular analysis of the adoption of surface-associated behaviours in Pseudomonas aeruginosa small colony variants
Final exams June 2019. Molecular Bacteriology, Twincore, Hannover
Julia Lahrberg GERMANY
supervisor: Prof. Dr. Eiz-Vesper, Transfusion Medicine, OE 8350,
project: Utilizing XCR1 expressing dendritic cells for cross-priming of antigen-specific CD8+ T cells
Final exam June 2017. Medical Writer at AMS (Advanced Medical Services GmbH), Mannheim
Ekaterina Legchenko RUSSIA
supervisor: Prof. Dr. Hansmann, Pediatric Cardiology, OE 6730,
project: Stem cell and anti-miR-mediated therapeutic interventions for pulmonary vascular disease and right ventricular failure
Final exam June 2017. Research Associate, Department of Medicine, University of Cambridge, UK
Ruisi Hazel Lin SINGAPORE
supervisor: Prof. Dr. Behrens, Clinical Immunology & Rheumatology, OE 6710,
project: Autophagy as culprit and target in HIV therapy
Final exam November 2018.
Katharina Lobschat GERMANY
supervisor: Prof. Dr. Arndt Vogel, Gastroenterology, OE 6810,
project: Identification of predictive factors for an anti PI3K therapy of hepatocellular carcinoma
Left program in December 2015!
Rishikesh Lotke INDIA
supervisor: Prof. Dr. Schulz, Virology, OE 5230,
project: Does the latent replication of gammaherpesviral genomes occur in a particular chromatin environment
Final exam June 2018. Experimental Ophthalmology, MHH
Tamrat Meshka Mamo Ethiopia
supervisor: Prof. Dr. Kispert, Molecular Biology, OE 5250,
project: Bmp signaling in ureter development
Final exam November 2017. Pediatric Nephrology, MHH; now Prosthetic Dentistry and Biomedical Materials, MHH
Neha Mishra INDIA
supervisor: Dr. Bossaller, Clinic for Immunology and Rheumatology, OE 6830,
project: Role of membrane-bound FasL in proinflammation and in murine lupus
Final exam June 2018. Rheumatology, Internal medicine, University Hospital Greifswald
Franziska Zumbrägel (née Pille) GERMANY
supervisor: Dr. Eschenburg/ Dr. Reubold, Biophysical Chemistry, OE 4350,
project: Protein complexes regulating the activity of caspase-9 in apoptosis
Final exam November 2016. Head of Life Science and Environment, catholic academy Stapelfeld
Celina Genschel (née Schauerte) GERMANY
supervisor: Dr. Lorentzen/ Prof. Dr. Thum, IMTTS, OE 8886,
project: Translation of anti-fibrotic microRNA strategies into a mouse model of fibrosis-associated chronic renal allograft dysfunction
Final exam November 2016. Scientist R & D, Cardior Pharmaceuticals GmbH, Hannover
Katharina Schimmel AUSTRIA
supervisor: Prof. Dr. Thum, IMTTS, OE 8886,
project: MicroRNA-mediated regulation of fibroblast migration after cardiac injury
Final exam November 2017. Cardiac Muscle Research Laboratory (CMRL), Cardiovascular Institute, Stanford University, USA
Anja Thorenz GERMANY
supervisor: Prof. Dr. Güler, Nephrology, OE 6840,
project: Complement factors C3 and C5 and the anaphylatoxin receptors in acute kidney injury and subsequent renal fibrosis
Final exam June 2017. Scientist in Biomarker Research, Bayer AG Pharmaceuticals, Wuppertal; now Study Manager Clinical Operations, Roche, Mannheim
Nadine Vollack GERMANY
supervisor: Dr. Tiede/ Dr. Werwitzke, Hematology and Oncology, OE 6860,
project: The role of the inhibitory FcyR2B in the pathogenesis of inhibitor formation in a murine model of Haemophilia A
Final exam June 2017. Haematology and Oncology, MHH.